Skip to contentSkip to filters

We use cookies for analytics.

NIDA Animal Genomics Program (U01 – Clinical Trial Not Allowed)

Genomics, Addiction Medicine, Epigenetics and research grant from National Institutes of Health

Apply by Thursday, Feb 11

Closing time not stated; check the source.

About

NIDA supports animal genomics research that explains genetic and epigenetic contributions to substance-use disorders and addiction-related phenotypes. Work may integrate molecular measurements, neural circuits, behaviour and computational methods to identify mechanisms and useful experimental resources. This U01 cooperative agreement permits projects lasting up to five years, with budgets based on the proposed work rather than a stated award cap. The next application deadline is 11 February 2027 at 5 p.m. in the applicant organisation’s local time. Clinical trials are not allowed.

Eligibility

Career stage: Not stated

Institution applies

Covers: Research support through a U01 cooperative agreement for up to five years. No individual award ceiling is specified; budgets must match project needs.

Host location: Worldwide

US and non-US applicant organisations are eligible under this NOFO. International activities remain subject to current NIH policies and the call conditions.

Eligibility source

Reviewed Sep 29, 2026. Check the funder’s full conditions before applying.

Eligible higher-education, nonprofit, for-profit and other organisations listed in the NOFO, including non-US organisations, apply through their institution. Required institutional registrations and the NOFO-specific research conditions apply.

Topics

animal genomicsaddiction

More from National Institutes of Health

Open jobs in Genomics

All jobs

Source: grants.nih.gov